Your browser doesn't support javascript.
loading
Geographical and sociodemographic epidemiology of inflammatory bowel disease in young females from 2010 to 2019.
Danpanichkul, Pojsakorn; Duangsonk, Kwanjit; Lopimpisuth, Chawin; Ho, Agnes Hiu-Yan; Fangsaard, Panisara; Sukphutanan, Banthoon; Pang, Yanfang; Chaisrimaneepan, Nattanicha; Dejvajara, Disatorn; Suenghataiphorn, Thanathip; Worapongpaiboon, Rinrada; Chaiyakunapruk, Nathorn; Lui, Rashid N; Kochhar, Gursimran Singh; Ng, Siew C; Farraye, Francis A; Wijarnpreecha, Karn.
  • Danpanichkul P; Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA; Immunology Unit, Department of Microbiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand. Electronic address: pojsakorndan@gmail.com.
  • Duangsonk K; Department of Microbiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
  • Lopimpisuth C; Department of Internal Medicine, University of Miami/ Jackson Memorial Hospital, Miami, Florida, USA.
  • Ho AH; Division of Gastroenterology and Hepatology, Department of Medicine and Therapeutics, Prince of Wales Hospital, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, SAR, China.
  • Fangsaard P; Department of Internal Medicine, Bassett Medical Center, Cooperstown, New York, USA.
  • Sukphutanan B; Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
  • Pang Y; Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, Guangxi 533000, China; National Immunological Laboratory of Traditional Chinese Medicine, Baise, Guangxi 533000, China; Key Laboratory of Research on Clinical Molecular Diagnosis for High Incidence Diseases in Western Guang
  • Chaisrimaneepan N; Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA.
  • Dejvajara D; Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
  • Suenghataiphorn T; Department of Internal Medicine, Griffin Hospital, Derby, Connecticut, USA.
  • Worapongpaiboon R; Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Chaiyakunapruk N; Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, Utah, USA; IDEAS Center, Veterans Affairs Salt Lake City Healthcare System, Salt Lake City, Utah, USA.
  • Lui RN; Division of Gastroenterology and Hepatology, Department of Medicine and Therapeutics, Prince of Wales Hospital, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, SAR, China.
  • Kochhar GS; Division of Gastroenterology, Hepatology & Nutrition, Allegheny Health Network, Pittsburgh, Pennsylvania, USA.
  • Ng SC; Division of Gastroenterology and Hepatology, Department of Medicine and Therapeutics, Prince of Wales Hospital, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, SAR, China.
  • Farraye FA; Inflammatory Bowel Disease Center, Division of Gastroenterology, Mayo Clinic, Jacksonville, Florida, USA.
  • Wijarnpreecha K; Division of Gastroenterology and Hepatology, Department of Medicine, University of Arizona College of Medicine, Phoenix, Arizona, USA; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Banner University Medical Center, Phoenix, Arizona, USA; BIO5 Institute, University of
Dig Liver Dis ; 2024 Jul 26.
Article en En | MEDLINE | ID: mdl-39068136
ABSTRACT
BACKGROUND AND

AIMS:

Inflammatory Bowel Disease (IBD) represents a significant health threat worldwide. However, there are deficiencies in large-scale epidemiological research focusing on these issues, especially among young women. We aim to examine the trend of IBD in young females globally.

METHODS:

We utilized data from the Global Burden of Disease (GBD) study between 2010 and 2019 to conduct a comprehensive analysis of the prevalence, mortality, and disability-adjusted life years (DALYs) from IBD in young females (15-49 years), stratified by region, nation, and sociodemographic index (SDI).

RESULTS:

Globally, there were 1.27 million (95 % UI 1.10 to 1.45 million) cases and 314,120 (95 % UI 240,880 to 395,420) DALYs from IBD in young females in 2019. Geographically, Europe had the highest burden of IBD in young females (n = 421,320). From 2010 to 2019, the prevalence rate increased in Africa (APC 0.34 %, 95 % CI 0.25 to 0.44 %), the Eastern Mediterranean (APC 0.77 %, 95 % CI 0.74 to 0.81 %), Europe (APC 0.48 %, 95 % CI 0.44 to 0.51 %) and the Western Pacific region (APC 1.01 %, 95 % CI 0.89 to 1.14 %). Countries with lower SDI exhibited higher DALYs to prevalence ratio. Over the study period, the percentage of young women with IBD compared to young adults increased by 0.24 %. This percentage varies significantly between countries, from 26 % to 62 %.

CONCLUSION:

The burden of IBD in young females is high and increasing. Countries with lower SDIs generate higher disability per case. This necessitates immediate and inclusive measures to tackle the rising burden of IBD in this vulnerable group. LAY

SUMMARY:

From 2010 to 2019, in the largest global epidemiology database, prevalence rates of inflammatory bowel disease in young females increased in many regions. Countries with lower socioeconomic development, as indicated by sociodemographic index, generated a higher burden compared to countries with higher development.
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2024 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2024 Tipo del documento: Article